Surviving Family Members

The Center for Psychedelic Research and Therapy at The University of Texas at Austin Dell Medical School is currently seeking individuals to participate in a paid research study that examines brain responses and how they may be altered following a course of treatment including psilocybin or 5-methoxydimethyltryptamine (5-MeO DMT) along with psychotherapy in bereaved spouses, significant others, or family members.

We hope to learn more about how brain function is influenced by psychedelic assisted therapy and how this may impact psychiatric symptoms related to the loss of a loved one. Family of military service members are prone to experiencing symptoms of complicated grief/prolonged grief disorder, particularly because military-related deaths often occur suddenly and without warning.

You may qualify for this study if you are:

  • Female, over the age of 18, and fluent in English.
  • Are currently experiencing mental health difficulties related to the death of a family member such as a spouse, parent, child, sibling, cousin, or other close relationship such as a long-term romantic partner.
  • Meet the criteria for prolonged grief.
  • Are not pregnant, planning to become pregnant, or claustrophobic.
  • Are willing and able to undergo fMRI brain scans, vision measures, and EEG with optional blood draw.
  • Are willing to travel to the Austin, TX Dell Med facility for fMRI scans, vision and EEG measurements.

Transportation and hotels at Austin will be covered, as will incidental expenses for meals and ground transportation. If the grieved, lost loved one was a veteran family member, then the cost of  your retreat will also be covered. Please contact us for more information!

Individuals can earn up to $925 for participation in this study and will additionally be provided two all-expenses paid trips to Austin, TX. You could also be reimbursed to hire a caregiver in your absence if you meet certain requirements. This is a prime opportunity to contribute to providing better mental health treatment for complicated grief/prolonged grief.

The study will test the hypothesis that the receipt of psilocybin or 5-MeO-DMT assisted psychotherapy will: (1) demonstrate therapeutic benefits for mental health symptoms of prolonged/complicated grief, depression, and posttraumatic stress symptoms; and (2) promote changes in brain function that show relationships to facets of clinical symptom change.

This study will measure changes in brain function utilizing functional magnetic resonance imaging (fMRI) and electroencephalographic recordings (EEG) that occur before and after participating in a retreat. Additional tests and measures will be performed.

1. Evidence of the current or prior history of psychosis or bipolar disorder as evidenced by self-report or clinical interview.

2. Unremovable ferrous metal in the body.

3. History of neurological disorder, stroke, seizures/convulsions (except febrile seizures in childhood), epilepsy, brain surgery, electroconvulsive or radiation treatment, brain hemorrhage or tumor, moderate-to-severe head injury or any penetrating head injury, or an uncontrolled thyroid disorder.

4. Current psychological and/or physical conditions that would be contraindicated for treatment with psilocybin or 5-MeO DMT, including, but not limited to, uncontrolled hypertension, cardiac arrhythmias, the taking of certain medications known to be contraindicated for use with serotonergic psychedelics (e.g., monoamine oxidase inhibitors), current active alcohol or drug dependence, and being pregnant or about to become pregnant.

If you would like to participate, the first step would be to complete a brief online questionnaire.

To best serve you, please use the referral code HHP when prompted by our online questionnaire.

Click here to fill out the form and we will get in touch.